| abstract |
Sulphonyl indirubin derivatives, the production thereof, the intermediates in the production thereof and the use thereof as a medicament for the treatment of cancer, such as concrete tumours and leukaemias; auto-immune diseases, such as psoriasis, alopecia and multiple sclerosis; chemotherapeutically-induced alopecia and mucositis; cardiovascular diseases, such as stenoses, arterioscleroses and restenoses; infectious diseases such as, for example, caused by uni-cellular parasites such as trypanosoma, toxoplasma or plasmodium, or nephrological diseases caused by fungii such as, for example, glomerulonephritis; chronic neurodegenerative diseases such as Huntington's disease, amyotrophic lateral scleroses, Parkinson's disease, AIDS dementia and Alzheimer's disease; acute neurodegenerative diseases such as cerebral ischaemia and neurological traumas and viral infections, such as for example cytomegalus infections, herpes, hepatitis B and C, and HIV diseases are disclosed. |